ADvantage Therapeutics Secures $2.5M NIH Grant to Advance Alzheimer’s Candidate AD04®

ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, announced it has been awarded a $2.5 mil...

September 30, 2025 | Tuesday | News
Concept Life Sciences Expands Integrated Drug Discovery Facilities in High Peak

Concept Life Sciences, a leading contract research organisation (CRO) serving the global life sciences and pharma industry, announces the official openin...

September 30, 2025 | Tuesday | News
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies

Avant Technologies Inc. announced a pivotal evolution in its business direction, emphasizing strategic partnerships through joint ventures and licensing ...

September 26, 2025 | Friday | News
Sanofi Ventures Secures $625M Boost, Expanding Assets to $1.4B

The fund will remain focused on Sanofi's key areas of immunology, rare diseases, neurology, and vaccines, backing earlier-stage innovation and emerging...

September 25, 2025 | Thursday | News
Ncardia Launches First iPSC-Derived Non-Human Primate Cardiomyocytes for Translational Cardiac Research

-Ncardia, a leader in stem cell–based solutions for drug discovery and safety assessment,  announced the launch of Ncyte® NHP-C vCardiomyo...

September 24, 2025 | Wednesday | News
Illumina Expands Global CDx Partnerships to Advance KRAS-Targeted Precision Oncology

Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the T...

September 24, 2025 | Wednesday | News
Esperion and Otsuka Secure MHLW Approval for NEXLETOL® in Japan to Treat Hypercholesterolemia

Esperion announced that Otsuka Pharmaceutical Co., Ltd. (Otsuka), the Company’s partner for the development and commercialization of NEXLETOL® ...

September 22, 2025 | Monday | News
Alvotech and Fuji Pharma Secure Japanese Approval for Three New Biosimilars: Denosumab, Golimumab, and Aflibercept

Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced th...

September 22, 2025 | Monday | News
Polyrizon Submits FDA Pre-Submission Package for PL-14 Allergy Blocker Nasal Spray

Polyrizon Ltd., a biotechnology company focusing on the development of intranasal products announced the submission of its full pre-submission (Pre-Sub) ...

September 22, 2025 | Monday | News
Merck Opens Climate-Neutral Life Science Facility in Blarney to Strengthen Global Biopharma Supply

Merck, a leading science and technology company,  announced the official opening of its new Life Science manufacturing facility in Blarney, Ireland....

September 19, 2025 | Friday | News
Sartorius and IMT Open “Lab Space” in Brazil to Advance Biotechnology Training and Innovation

  Sartorius, a leading international partner of life science research and the biopharmaceutical industry,  announced the opening of its new appl...

September 19, 2025 | Friday | News
AccuStem Sciences and EmeritusDX Expand Blood-Based Cancer Testing Capabilities with Advanced miRNA Platform

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, annou...

September 18, 2025 | Thursday | News
Monte Rosa Therapeutics and Novartis Expand Collaboration with New $120M Upfront Deal to Develop Novel Immunology Degraders

Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s...

September 16, 2025 | Tuesday | News
Thermo Fisher Scientific Launches Olink® Target 48 Neurodegeneration Panel for Absolute Quantification of Key Biomarkers

Targeted proteomics panel delivers absolute quantification of key and emerging biomarkers in one scalable assay Thermo Fisher Scientific Inc., the world...

September 16, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close